title: Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test.
abstract: BACKGROUND
  The 6-minute walk test (6 MWT) is used to measure exercise capacity and assess prognosis in interstitial lung disease (ILD). Although the 6 MWT is usually considered to be a test of submaximal exercise capacity in ILD, the physiological load imposed by this test is not well described and 6 MWT outcomes are poorly understood. This study aimed to compare cardiorespiratory responses to 6 MWT and cardiopulmonary exercise test (CPET) in people with ILD.
  
  
  METHODS
  47 participants with ILD (27 idiopathic pulmonary fibrosis (IPF), mean age 71 (SD 12) years, diffusing capacity for carbon monoxide (TLCO) 49(15) %predicted) undertook CPET and 6 MWT on the same day in random order. Oxygen uptake (VO(2)), ventilation (VE) and carbon dioxide production (VCO2) were assessed during each test using a portable metabolic cart.
  
  
  RESULTS
  The VO(2)peak during the 6 MWT was lower than during CPET (1.17(0.27) vs 1.30(0.37) L.min-1, p = 0.001), representing an average of 94% (range 62-135%) of CPET VO(2)peak. Achieving a higher percentage of CPET VO(2)peak on 6 MWT was associated with lower TLCO %predicted (r = -0.43, p = 0.003) and more desaturation during walking (r = -0.46, p = 0.01). The VEpeak and VCO(2)peak were significantly lower during 6 MWT than CPET (p < 0.05). However, participants desaturated more during the 6 MWT (86(6)% vs 89(4)%, p < 0.001). The degree of desaturation was not affected by the percent of peak VO2 achieved during the 6 MWT. Responses were similar in the subgroup with IPF.
  
  
  CONCLUSIONS
  On average, the 6 MWT elicits a high but submaximal oxygen uptake in people with ILD. However the physiological load varies between individuals, with higher peak VO2 in those with more severe disease that may match or exceed that achieved on CPET. The 6 MWT is not always a test of submaximal exercise capacity in people with ILD.
authors.affiliation: Alfred Health, Melbourne, Australia. a.holland@alfred.org.au.
authors.forename: Anne E
authors.initials: AE
authors.lastname: Holland
authors.forename: Leona
authors.initials: L
authors.lastname: Dowman
authors.forename: Julio
authors.initials: J
authors.lastname: Fiore
authors.forename: Danny
authors.initials: D
authors.lastname: Brazzale
authors.forename: Catherine J
authors.initials: CJ
authors.lastname: Hill
authors.forename: Christine F
authors.initials: CF
authors.lastname: McDonald
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002245:Carbon Dioxide / Q000378:metabolism; D005080:Exercise Test / Q000379:methods*; D017079:Exercise Tolerance / Q000502:physiology; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption; D010108:Oxyhemoglobins / Q000378:metabolism; D011653:Pulmonary Diffusing Capacity; D012123:Pulmonary Ventilation; D013997:Time Factors; D016138:Walking / Q000502:physiology*
chemical_list: D010108:Oxyhemoglobins; D002245:Carbon Dioxide
references.citation: Respir Med. 2003 May;97(5):482-90
references.pmid: 12735664
references.citation: Med Sci Sports Exerc. 2000 Aug;32(8):1365-8
references.pmid: 10948999
references.citation: Chest. 2007 Nov;132(5):1500-5
references.pmid: 17925427
references.citation: Am J Respir Crit Care Med. 2005 May 15;171(10):1150-7
references.pmid: 15640367
references.citation: Eur Respir J. 2007 Oct;30(4):715-21
references.pmid: 17626111
references.citation: Am J Respir Crit Care Med. 2003 Nov 1;168(9):1084-90
references.pmid: 12917227
references.citation: Am J Respir Crit Care Med. 2006 Sep 15;174(6):659-64
references.pmid: 16778159
references.citation: Chest. 2011 Aug;140(2):351-358
references.pmid: 21273296
references.citation: Respir Med. 2009 Jan;103(1):117-23
references.pmid: 18786822
references.citation: Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
references.pmid: 21471066
references.citation: Eur Respir J. 2005 Jan;25(1):96-103
references.pmid: 15640329
references.citation: Am J Respir Crit Care Med. 2012 May 15;185(10):1044-8
references.pmid: 22505745
references.citation: Arch Bronconeumol. 2010 Mar;46(3):122-8
references.pmid: 20138698
references.citation: Respirology. 2008 Nov;13(6):856-62
references.pmid: 18811884
references.citation: Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1063-72
references.pmid: 9563720
references.citation: Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
references.pmid: 12091180
references.citation: Chron Respir Dis. 2010;7(2):101-11
references.pmid: 20056733
references.citation: Am J Respir Crit Care Med. 2009 Mar 1;179(5):402-7
references.pmid: 19074597
references.citation: Respir Med. 2005 Nov;99(11):1431-9
references.pmid: 15885995
references.citation: J Rheumatol. 2009 Feb;36(2):330-6
references.pmid: 19208563
references.citation: Respirology. 2012 Feb;17(2):278-84
references.pmid: 22008290
references.citation: Am J Respir Crit Care Med. 2006 Oct 1;174(7):803-9
references.pmid: 16825656
references.citation: Am J Respir Crit Care Med. 2011 May 1;183(9):1231-7
references.pmid: 21131468
references.citation: Thorax. 2008 Sep;63 Suppl 5:v1-58
references.pmid: 18757459
references.citation: Eur Respir J. 2002 Sep;20(3):564-9
references.pmid: 12358329
references.citation: Sarcoidosis Vasc Diffuse Lung Dis. 2001 Jun;18(2):170-5
references.pmid: 11436537